Coexistence and outcome of coronary artery disease in Takotsubo syndrome

European Heart Journal

2 June 2020
Organised by: Logo
ESC Journals CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Coronary Syndromes

Abstract

AbstractAims

Takotsubo syndrome (TTS) is an acute heart failure syndrome, which shares many features with acute coronary syndrome (ACS). Although TTS was initially described with angiographically normal coronary arteries, smaller studies recently indicated a potential coexistence of coronary artery disease (CAD) in TTS patients. This study aimed to determine the coexistence, features, and prognostic role of CAD in a large cohort of patients with TTS.

Methods and results

Coronary anatomy and CAD were studied in patients diagnosed with TTS. Inclusion criteria were compliance with the International Takotsubo Diagnostic Criteria for TTS, and availability of original coronary angiographies with ventriculography performed during the acute phase. Exclusion criteria were missing views, poor quality of angiography loops, and angiography without ventriculography. A total of 1016 TTS patients were studied. Of those, 23.0% had obstructive CAD, 41.2% had non-obstructive CAD, and 35.7% had angiographically normal coronary arteries. A total of 47 patients (4.6%) underwent percutaneous coronary intervention, and 3 patients had acute and 8 had chronic coronary artery occlusion concomitant with TTS, respectively. The presence of CAD was associated with increased incidence of shock, ventilation, and death from any cause. After adjusting for confounders, the presence of obstructive CAD was associated with mortality at 30 days. Takotsubo syndrome patients with obstructive CAD were at comparable risk for shock and death and nearly at twice the risk for ventilation compared to an age- and sex-matched ACS cohort.

Conclusions

Coronary artery disease frequently coexists in TTS patients, presents with the whole spectrum of coronary pathology including acute coronary occlusion, and is associated with adverse outcome.

Trial registration

ClinicalTrials.gov number: NCT01947621.

Contributors

Wolfgang Dichtl
Wolfgang Dichtl

Author

Innsbruck Medical University Innsbruck , Austria

Clément Delmas
Clément Delmas

Author

Toulouse Rangueil University Hospital of Toulouse Toulouse , France

Olivier Lairez
Olivier Lairez

Author

University of Toulouse Toulouse , France

Michel Noutsias
Michel Noutsias

Author

Cardio-Home&Mind Berlin Berlin , Germany

Roman Pfister
Roman Pfister

Author

Cologne University Hospital - Heart Center Cologne , Germany

Philippe Meyer
Philippe Meyer

Author

University Hospital of Geneva Geneva , Switzerland

Claudio Bilato
Claudio Bilato

Author

West Vicenza General Hospitals Vicenza , Italy

Ken Kato
Ken Kato

Author

Matteo Bianco
Matteo Bianco

Author

San Luigi Gonzaga University Hospital Orbassano , Italy

Fausto J Pinto
Fausto J Pinto

Author

Hospital de Santa Maria Faculty of Medicine Lisbon , Portugal

ESC 365 is supported by